title: Human papilloma virus vaccination in Nepal: an initial experience in Nepal.
authors.affiliation: Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal. yp_singh@hotmail.com
authors.forename: Yogendra
authors.initials: Y
authors.lastname: Singh
authors.forename: Aarti
authors.initials: A
authors.lastname: Shah
authors.forename: Meeta
authors.initials: M
authors.lastname: Singh
authors.forename: Sheela
authors.initials: S
authors.lastname: Verma
authors.forename: Bhakta Man
authors.initials: BM
authors.lastname: Shrestha
authors.forename: Prabhu
authors.initials: P
authors.lastname: Vaidya
authors.forename: Radha Pyari
authors.initials: RP
authors.lastname: Nakarmi
authors.forename: Surendra Bb
authors.initials: SB
authors.lastname: Shrestha
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008297:Male; D009390:Nepal / Q000453:epidemiology; D027383:Papillomaviridae / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D053918:Papillomavirus Vaccines / Q000276:immunology / Q000627:therapeutic use*; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000209:etiology* / Q000517:prevention & control*; D014611:Vaccination; D055815:Young Adult
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines